Cargando…
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
PURPOSE: Among the retinal vascular diseases, burden of retinal vein occlusion is most common immediately after diabetic retinopathy. Intravitreal corticosteroids are gaining popularity in managing macular edema (ME) of RVO. Our study compares efficacy and safety of intravitreal triamcinolone (IVTA)...
Autores principales: | Mishra, S. K., Gupta, A., Patyal, S., Kumar, S., Raji, K., Singh, A., Sharma, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883339/ https://www.ncbi.nlm.nih.gov/pubmed/29632703 http://dx.doi.org/10.1186/s40942-018-0114-2 |
Ejemplares similares
-
Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion
por: Zhang, Shuang, et al.
Publicado: (2016) -
Early versus Late Intravitreal Triamcinolone Acetonide for Macular Edema associated with Branch Retinal Vein Occlusion
por: Oh, Joo Youn, et al.
Publicado: (2007) -
Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
por: Yoo, Seul Gi, et al.
Publicado: (2015) -
Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion
por: Noma, Hidetaka, et al.
Publicado: (2012) -
Retinal sensitivity improvement after intravitreal triamcinolone acetonide injection for macular edema secondary to branch retinal vein occlusion
por: Senturk, Fevzi, et al.
Publicado: (2013)